Management of hepatitis C in opioid agonist therapy patients of the Swiss canton Aargau within and outside the cohort study.

MLA

Schürch, Sophie, et al. “Management of Hepatitis C in Opioid Agonist Therapy Patients of the Swiss Canton Aargau within and Outside the Cohort Study.” Swiss Medical Weekly, vol. 150, Aug. 2020, p. w20317. EBSCOhost, https://doi.org/10.4414/smw.2020.20317.

APA

Schürch, S., Fux, C. A., Dehler, S., Conen, A., Knuchel, J., Friedl, A., Eigenmann, F., Roser, P., Ackle, P., & Bregenzer, A. (2020). Management of hepatitis C in opioid agonist therapy patients of the Swiss canton Aargau within and outside the cohort study. Swiss Medical Weekly, 150, w20317. https://doi.org/10.4414/smw.2020.20317

Chicago

Schürch, Sophie, Christoph A Fux, Silvia Dehler, Anna Conen, Jürg Knuchel, Andrée Friedl, Franz Eigenmann, Patrik Roser, Peter Ackle, and Andrea Bregenzer. 2020. “Management of Hepatitis C in Opioid Agonist Therapy Patients of the Swiss Canton Aargau within and Outside the Cohort Study.” Swiss Medical Weekly 150 (August): w20317. doi:10.4414/smw.2020.20317.